Skip to main content
OpenTrials

Clinical trial condition

Hypoparathyroidism

Explore clinical trials studying Hypoparathyroidism. Study availability and eligibility vary by location and protocol.

92 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Hypoparathyroidism trial results

Completed

Study of Safety and Efficacy of a rhPTH[1-84] of Fixed Doses of 25 and 50 mcg in Adults With Hypoparathyroidism (RELAY)

NCT01268098

Conditions
Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations
  • Advance Medical Research LLC Lakewood, California, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details
Completed

Use of NPSP558 in the Treatment of Hypoparathyroidism

NCT00732615

Conditions
Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations
  • Mayo Clinic-Scottsdale Scottsdale, Arizona, United States
  • Advance Medical Research LLC Lakewood, California, United States
  • Diabetes Associates Orange, California, United States
  • University of California-San Francisco VA Medical Center San Francisco, California, United States
View all 31 locations
View Trial Details
Completed

A Open-label Study Investigating the Safety and Tolerability of NPSP558, a Recombinant Human Parathyroid Hormone (rhPTH [1-84]), for the Treatment of Adults With Hypoparathyroidism - A Clinical Extension Study (RACE)

NCT01297309

Conditions
Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations
  • Advance Medical Research LLC Lakewood, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • University of Chicago Medical Center Chicago, Illinois, United States
  • Indiana University School of Medicine Indianapolis, Indiana, United States
View all 14 locations
View Trial Details
Completed

Study to Assess the Blood Concentrations and Actions of Recombinant Human Parathyroid Hormone (rhPTH [1-84]) When Given Once and Twice Daily to Participants With Hypoparathyroidism

NCT02781844

Conditions
Endocrine System Diseases, Hypoparathyroidism, Parathyroid Diseases
Locations
  • Providence Clinical Research North Hollywood, California, United States
  • Indiana University Indianapolis, Indiana, United States
  • University Of Kentucky School of Medicine Lexington, Kentucky, United States
  • Crescent City Clinical Research Center, LLC Metairie, Louisiana, United States
View all 15 locations
View Trial Details

Related conditions